Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 2Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia 1Congenital Abnormalities 1

Interventions

Cytarabine 30Filgrastim 12Daunorubicin 11Busulfan 11Idarubicin 10Peripheral Blood Stem Cell Transplantation 9Etoposide 9fludarabine phosphate 8Mitoxantrone 7Methotrexate 7Gemtuzumab 7sargramostim 6Cyclosporine 6Decitabine 5Cyclophosphamide 5Azacitidine 5Antilymphocyte Serum 5tipifarnib 4alvocidib 4Tacrolimus 4Whole-Body Irradiation 3Vorinostat 3Radiotherapy 3Mycophenolic Acid 3Injections 3Granulocyte Colony-Stimulating Factor 3Clofarabine 3Biopsy 3merphos 2entinostat 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Myelomonocytic, Acute × choline magnesium trisalicylate × Clear all
NCT02144675 2021-08-24

Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia

Rutgers, The State University of New Jersey

Phase 2 Completed
27 enrolled 9 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡